Urinary Aquaporin 2 Excretion After NSAID in Fasting Healthy Human

NCT00281762 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-05-09

No results posted yet for this study

Summary

We wanted to test the hypothesis that prostaglandin inhibition reduces the down regulation of u-AQP-2 induced by fasting

Conditions

  • Healthy

Interventions

DRUG

NSAID

Sponsors & Collaborators

  • Regional Hospital Holstebro

    lead OTHER

Principal Investigators

  • Erling B Pedersen, Professor · Regional Hospital Holstebro

  • Thomas G Knudsen, MD · Regional Hospital Holstebro

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
Healthy Volunteers
Yes

Timeline & Regulatory

Primary Completion
2007-01-31
Completion
2007-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00281762 on ClinicalTrials.gov